These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2785254)

  • 21. Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells.
    Nievergall E; Ramshaw HS; Yong AS; Biondo M; Busfield SJ; Vairo G; Lopez AF; Hughes TP; White DL; Hiwase DK
    Blood; 2014 Feb; 123(8):1218-28. PubMed ID: 24363400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells in chronic leukemia. Function and markers.
    Sørskaar D; Førre O; Stavem P
    Int Arch Allergy Appl Immunol; 1988; 87(2):159-64. PubMed ID: 2973442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer.
    Kono K; Takahashi A; Ichihara F; Sugai H; Fujii H; Matsumoto Y
    Cancer Res; 2002 Oct; 62(20):5813-7. PubMed ID: 12384543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.
    Hauch M; Gazzola MV; Small T; Bordignon C; Barnett L; Cunningham I; Castro-Malaspinia H; O'Reilly RJ; Keever CA
    Blood; 1990 Jun; 75(11):2250-62. PubMed ID: 2189508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity.
    Verfaillie C; Miller W; Kay N; McGlave P
    Blood; 1989 Aug; 74(2):793-7. PubMed ID: 2473805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy.
    Chiplunkar SV; Deshmukh MV; Samson PD; Butlin R; Bhatki WS; Chulawalla RG; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):334-41. PubMed ID: 2376683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells.
    Carson WE; Parihar R; Lindemann MJ; Personeni N; Dierksheide J; Meropol NJ; Baselga J; Caligiuri MA
    Eur J Immunol; 2001 Oct; 31(10):3016-25. PubMed ID: 11592078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
    Pendurthi TK; Parker R; Schlom J; Primus FJ
    Int J Cancer; 1990 Dec; 46(6):1021-8. PubMed ID: 2123477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.
    Poaty-Mavoungou V; Touré FS; Tevi-Benissan C; Mavoungou E
    Viral Immunol; 2002; 15(1):197-212. PubMed ID: 11952142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
    Mani R; Rajgolikar G; Nunes J; Zapolnik K; Wasmuth R; Mo X; Byrd JC; Lee DA; Muthusamy N; Vasu S
    Cytotherapy; 2020 Jul; 22(7):369-376. PubMed ID: 32303428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells.
    Fantini M; David JM; Wong HC; Annunziata CM; Arlen PM; Tsang KY
    Cancer Biother Radiopharm; 2019 Apr; 34(3):147-159. PubMed ID: 30601063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.
    Merrill JE
    J Clin Immunol; 1983 Jan; 3(1):42-50. PubMed ID: 6219125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of human natural killer cell activity by recombinant human interleukin 2.
    Shaw AR; Bleackley RC; Merryweather JP; Barr PJ
    Cell Immunol; 1985 Mar; 91(1):193-200. PubMed ID: 3871664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.
    Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf I
    Cytokine; 2000 Jun; 12(6):756-61. PubMed ID: 10843759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
    Uchiyama T; Sato N; Narita M; Yamahira A; Iwabuchi M; Furukawa T; Sone H; Takahashi M
    Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.